# Launchpad Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/launchpad-therapeutics

- Industry: Healthcare Specialists
- Headquarters: US
- Website: www.launchpadtherapeutics.com
- Total disclosed funding: $10M
- Latest round: Series A (Dec 9, 2022)
- Investors on record: 2

## About

Based in Rhode Island, US, and founded in 2022 as a spinout from Black Diamond, Launchpad Therapeutics, Inc., operates as an oncology company that offers artificial intelligence-based and structure-supported drug design solutions for the treatment of cancer. In December 2022, Launchpad Therapeutics, Inc. raised USD 30 million in Series A funding from investors New Enterprise Associates and Versant Ventures.

The company offers various therapeutic solutions for next-generation anti-cancer therapeutics for portfolio commercialization that include the delivery of novel monoclonal antibody (mAb) designs. The company also provides pharmaceutical research solutions, including needs exploration and pre-market assessment, drug design, development, and testing.

## Funding rounds

- Series A, Dec 9, 2022, $10M — New Enterprise Associates, Versant Ventures

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A